Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial

Kalifa A Bojang, Francis Akor, Lesong Conteh, Emily Webb, Ousman Bittaye, David J Conway, Momodou Jasseh, Virginia Wiseman, Paul J Milligan, Brian Greenwood, Kalifa A Bojang, Francis Akor, Lesong Conteh, Emily Webb, Ousman Bittaye, David J Conway, Momodou Jasseh, Virginia Wiseman, Paul J Milligan, Brian Greenwood

Abstract

Background: The Expanded Programme on Immunisation (EPI) provides an effective way of delivering intermittent preventive treatment for malaria (IPT) to infants. However, it is uncertain how IPT can be delivered most effectively to older children. Therefore, we have compared two approaches to the delivery of IPT to Gambian children: distribution by village health workers (VHWs) or through reproductive and child health (RCH) trekking teams. In rural areas, RCH trekking teams provide most of the health care to children under the age of 5 years in the Infant Welfare Clinic, and provide antenatal care for pregnant women.

Methods and findings: During the 2006 malaria transmission season, the catchment populations of 26 RCH trekking clinics in The Gambia, each with 400-500 children 6 years of age and under, were randomly allocated to receive IPT from an RCH trekking team or from a VHW. Treatment with a single dose of sulfadoxine pyrimethamine (SP) plus three doses of amodiaquine (AQ) were given at monthly intervals during the malaria transmission season. Morbidity from malaria was monitored passively throughout the malaria transmission season in all children, and a random sample of study children from each cluster was examined at the end of the malaria transmission season. The primary study endpoint was the incidence of malaria. Secondary endpoints included coverage of IPTc, mean haemoglobin (Hb) concentration, and the prevalence of asexual malaria parasitaemia at the end of malaria transmission period. Financial and economic costs associated with the two delivery strategies were collected and incremental cost and effects were compared. A nested case-control study was used to estimate efficacy of IPT treatment courses. Treatment with SP plus AQ was safe and well tolerated. There were 49 cases of malaria with parasitaemia above 5,000/µl in the areas where IPT was delivered through RCH clinics and 21 cases in the areas where IPT was delivered by VHWs, (incidence rates 2.8 and 1.2 per 1,000 child months, respectively, rate difference 1.6 [95% confidence interval (CI) -0.24 to 3.5]). Delivery through VHWs achieved a substantially higher coverage level of three courses of IPT than delivery by RCH trekking teams (74% versus 48%, a difference of 27% [95% CI 16%-38%]). For both methods of delivery, coverage was unrelated to indices of wealth, with similar coverage being achieved in the poorest and wealthiest groups. The prevalence of anaemia was low in both arms of the trial at the end of the transmission season. Efficacy of IPTc against malaria during the month after each treatment course was 87% (95% CI 54%-96%). Delivery of IPTc by VHWs was less costly in both economic and financial terms than delivery through RCH trekking teams, resulting in incremental savings of US$872 and US$1,244 respectively. The annual economic cost of delivering at least the first dose of each course of IPTc was US$3.47 and US$1.63 per child using trekking team and VHWs respectively.

Conclusions: In this setting in The Gambia, delivery of IPTc to children 6 years of age and under by VHWs is more effective and less costly than delivery through RCH trekking clinics.

Trial registration: ClinicalTrials.gov NCT00376155. Please see later in the article for the Editors' Summary.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1. Trial profile.
Figure 1. Trial profile.

References

    1. Bradley-Moore AM, Greenwood BM, Bradley AK, Bartlett A, Bidwell DE, et al. Malaria chemoprophylaxis with chloroquine in young Nigerian children. 1. Its effect on mortality, morbidity and prevalence of malaria. Ann Trop Med Parasitol. 1985;79:549–562.
    1. Greenwood BM, Greenwood AM, Bradley AK, Snow RW, Byass P, et al. Comparison of two strategies for control of malaria within a primary health care programme in The Gambia. Lancet. 1988;1:1121–1127.
    1. Alonso PL, Lindsay SW, Armstrong JR, Conteh M, Hill AGM, et al. The effect of insecticide-treated bed nets on mortality of Gambian children. Lancet. 1991;337:1499–1502.
    1. Menon A, Snow RW, Byass P, Greenwood BM, Hayes RJ. Sustained protection against mortality and morbidity from malaria in rural Gambian children by chemoprophylaxis given by village health workers. Trans R Soc Trop Med Hyg. 1990;85:768–772.
    1. Menendez C, Kahigwa E, Hirt R, Vounatsou P, Aponte JJ, et al. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet. 1997;350:844–850.
    1. Laing AB. The impact of malaria chemoprophylaxis in Africa with special reference to Madagascar, Cameroon, and Senegal. Bull World Health Organ. 1984;62:41–48.
    1. Pringle G, Avery-Jones S. Observations on the early course of untreated falciparum malaria in semi-immune African children following a short period of protection. Bull World Health Organ. 1966;35:269–272.
    1. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, et al. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg. 1994;51:515–522.
    1. Shulman CE, Dorman EK, Cutts F, Kaswondo K, Bulmer JN, et al. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet. 1999;353:632–636.
    1. Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango C, et al. Intermittent sulphadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. Trans R Soc Trop Med Hyg. 2000;94:549–553.
    1. Greenwood B. Intermittent preventive antimalarial treatment in infants. Clin Infect Dis. 2007;45:26–28.
    1. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, et al. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet. 2009;374:1533–1542.
    1. Etard JF, Le Hesran JY, Diallo A, Diallo JP, Ndiaye JL, et al. Childhood mortality and probable causes of death using verbal autopsy in Niakhar, Senegal, 1989–2000. Int J Epidemiol. 2004;33:1286–1292.
    1. Jaffar S, Leach A, Greenwood AM, Jepson A, Muller O, et al. Changes in the pattern of infant and childhood mortality in upper river division, The Gambia, from 1989 to 1993. Trop Med Int Health. 1997;2:28–37.
    1. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, et al. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet. 2008;372:1545–1554.
    1. Dicko A, Sagara I, Sissoko MS, Guinod O, Diallo AI, et al. Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Malar J. 2008;7:123.
    1. Cissé B, Sokhna C, Boulanger D, Millet J, Seidu M, et al. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet. 2006;367:659–667.
    1. Kweku M, Liu D, Adjuik M, et al. Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS One. 2008;3:e4000. doi: .
    1. Konaté AT, Yaro J, Ouédraogo AZ, Diarra A, Gansané A, et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide treated bednet in Burkina Faso. PLoS Med. 2011;8:e1000408. doi: .
    1. Dicko A, Diallo AI, Tembine I, Dicko Y, Dara N, et al. A randomised, placebo-controlled trial of intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine plus amodiaquine in children protected by a long lasting insecticide treated net in Mali. PLoS Med. 2011;8:e1000407. doi: .
    1. Greenwood BM, Pickering H. A review of the epidemiology and control of malaria in The Gambia, West Africa. Tran Roy Soc Trop Med Hyg. 1993;87:3–11.
    1. The Gambia Bureau of Statistics, MICS. Banjul: The Gambia Bureau of Statistics; 2007. The Gambia Multiple Indicator Cluster Survey 2005/6.103
    1. Dunyo S, Ord R, Hallett R, Jawara M, Walraven G, et al. Randomised trial of chloroquine/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparum. PLoS Clin Trials. 2006;1:e14. doi: .
    1. Smith PG, Morrow R. London: Macmillan; 1996. Field trials of health interventions in developing countries; a toolbox.
    1. Greenwood BM, Armstrong JRM. Comparison of two simple methods for determining malaria parasite density. Tran Roy Soc Trop Med Hyg. 1991;85:186–88.
    1. Johns B, Baltussen R, Hutubessy R. Programme costs in the economic evaluation of health interventions. Cost Eff Res Alloc. 2003;1:1.
    1. Tan-Torres T, Baltussen R, Adam T, Hutubessy R, Acharya A, et al. Making choices in health: WHO guide to cost-effectiveness analysis. 2003. . Geneva: World Health Organization.
    1. Kish L. New York: John Wiley & Sons; 1965. Survey sampling.195
    1. Bennett S, Parpia T, Hayes R, Cousens S. Methods for the analysis of incidence rates in cluster randomized trials. Int J Epidemiol. 2002;31:839–846.
    1. D'Alessandro U, Olaleye BO, McGuire W, Langerock P, Bennett S, et al. Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet. 1995;345:479–483.
    1. Kweku M, Webster J, Adjuik M, Abudey S, Greenwood B, et al. Options for the delivery of intermittent preventive treatment for malaria to children: a community randomised trial. PLoS One. 2009;4:e7256. doi: .
    1. Allen SJ, Snow RW, Menon A, Greenwood BM. Compliance with malaria chemoprophylaxis over a five year period among children in a rural area of the Gambia. J Trop Med Hyg. 1990;93:313–322.
    1. Sokhna C, Cissé B, Bâ el H, Milligan P, Hallett R, et al. A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One. 2008;3:e1471. doi: .
    1. Cisse B, Cairns M, Faye E, NDiaye O, Faye B, et al. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. PLoS One. 2009;4:e7164. doi: .
    1. Bojang KA, Akor F, Bittaye O, Conway D, Bottomley C, et al. A randomised trial to compare the safety, tolerability and efficacy of three potential drug combinations for intermittent preventive treatment in children. PLoS One. 2010;5:e11225. doi: .
    1. Kolaczinski J, Hanson K. Costing the distribution of insecticide-treated nets: a review of cost and cost-effectiveness studies to provide guidance on standardization of costing methodology. Mal J. 2006;5:37.
    1. Conteh L, Sharp BL, Streat E, Barreto A, Konar S. The cost and cost-effectiveness of malaria vector control by residual insecticide house-spraying in southern Mozambique: a rural and urban analysis. Trop Med Int Health. 2004;9:125–132.
    1. Manzi F, Hutton G, Schellenberg J, Tanner M, Alonso P, et al. From strategy development to routine implementation: the cost of Intermittent Preventive Treatment in Infants for malaria control. BMC Health Serv Res. 2008;8:165.
    1. Temperley M, Mueller D, Njagi JK, Akwale W, Clarke SE, et al. Costs and cost-effectiveness of delivering intermittent preventive treatment through schools in western Kenya. Malaria J. 2008;7:196.
    1. Conteh L, Patouillard E, Kweku M, Legood R, Greenwood B, et al. Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian Children. PLoS One. 2010;5:e12223. doi: .
    1. Sesay Sanie, Milligan Paul, Touray Ensa, Sowe Maimuna, Webb EmilyL, et al. A trial of intermittent preventive treatment and home based management of malaria in a rural area of The Gambia. Mal J In press 2010
    1. Haines A, Sanders D, Lehmann U, Rowe AK, Lawn JE, et al. Achieving child survival goals: potential contribution of community health workers. Lancet. 2007;369:2121–2131.
    1. Lehmann U, Sanders D. Community health workers: what do we know about them? 2007. Available: . Accessed 6 September 2010.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅